Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel and Platinum CCRT vs Platinum CCRT in Postoperative G-EAC
NCT06870565Phase 3Not yet recruiting
- Sponsor
- Women's Hospital, Zhejiang University School of Medicine
- Start
- Mar 2025
- Primary completion
- Dec 2029
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
01
Overview
A Phase 3 trial of Paclitaxel Micelles for Injection in gastric-type endocervical adenocarcinoma (GAS), sponsored by Women's Hospital, Zhejiang University School of Medicine. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
gastric-type endocervical adenocarcinoma (GAS)
Beyond the preview
Go deeper on NCT06870565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06870565.